{"disease":{"id":"usher-syndrome","name":"usher syndrome"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03655223","title":"Early Check: Expanded Screening in Newborns","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":30000,"lead_sponsor_name":"RTI International","has_results":false},{"nct_id":"NCT04665726","title":"Natural History Study of Usher Syndrome ( Light4Deaf )","phase":"","overall_status":"RECRUITING","enrollment_count":400,"lead_sponsor_name":"Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts","has_results":false},{"nct_id":"NCT00106743","title":"Natural History and Genetic Studies of Usher Syndrome","phase":"","overall_status":"COMPLETED","enrollment_count":249,"lead_sponsor_name":"National Eye Institute (NEI)","has_results":false},{"nct_id":"NCT03901391","title":"Prospective Open Clinical and Genetic Study of Patients With Retinitis Pigmentosa","phase":"","overall_status":"COMPLETED","enrollment_count":130,"lead_sponsor_name":"Sensor Technology for Deafblind","has_results":false},{"nct_id":"NCT05355415","title":"Adaptive Optics Imaging of Outer Retinal Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Food and Drug Administration (FDA)","has_results":false},{"nct_id":"NCT06592131","title":"BF844 Safety and Pharmacokinetic Study in Healthy Volunteers","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":76,"lead_sponsor_name":"EyeXCel Pty. Ltd.","has_results":false},{"nct_id":"NCT05142670","title":"Task-oriented Training for Patients With Pusher Syndrome","phase":"NA","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"Hunan Provincial People's Hospital","has_results":false},{"nct_id":"NCT03814499","title":"Natural History Study in Subjects With Usher Syndrome","phase":"","overall_status":"COMPLETED","enrollment_count":56,"lead_sponsor_name":"Fondazione Telethon","has_results":true},{"nct_id":"NCT04820244","title":"Characterizing Rate of Progression in USHer Syndrome (CRUSH) Study","phase":"","overall_status":"UNKNOWN","enrollment_count":36,"lead_sponsor_name":"Radboud University Medical Center","has_results":false},{"nct_id":"NCT04906135","title":"Auditory Neural Function in Implanted Patients With Usher Syndrome","phase":"NA","overall_status":"COMPLETED","enrollment_count":29,"lead_sponsor_name":"Ohio State University","has_results":false},{"nct_id":"NCT03319524","title":"Clinical and Genetic Testing of Patients With Usher Syndrome","phase":"","overall_status":"COMPLETED","enrollment_count":28,"lead_sponsor_name":"Sensor Technology for Deafblind","has_results":false},{"nct_id":"NCT05085964","title":"An Open-Label Extension Study to Evaluate Safety & Tolerability of QR-421a in Subjects With Retinitis Pigmentosa","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":21,"lead_sponsor_name":"Laboratoires Thea","has_results":true},{"nct_id":"NCT03780257","title":"Study to Evaluate Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"ProQR Therapeutics","has_results":false},{"nct_id":"NCT03991390","title":"Effectiveness of Balance Exercise Program for Stroke Patients With Pusher Syndrome","phase":"NA","overall_status":"COMPLETED","enrollment_count":16,"lead_sponsor_name":"Parc Sanitari Pere Virgili","has_results":false},{"nct_id":"NCT02065011","title":"A Study to Determine the Long-Term Safety, Tolerability and Biological Activity of SAR421869 in Patients With Usher Syndrome Type 1B","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":9,"lead_sponsor_name":"Sanofi","has_results":false},{"nct_id":"NCT01505062","title":"Study of SAR421869 in Participants With Retinitis Pigmentosa Associated With Usher Syndrome Type 1B","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":9,"lead_sponsor_name":"Sanofi","has_results":true},{"nct_id":"NCT05158296","title":"Study to Evaluate the Efficacy Safety and Tolerability of Ultevursen in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene (Sirius)","phase":"PHASE2, PHASE3","overall_status":"TERMINATED","enrollment_count":7,"lead_sponsor_name":"Laboratoires Thea","has_results":true},{"nct_id":"NCT05176717","title":"Study to Evaluate the Efficacy Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene With Early to Moderate Vision Loss (Celeste)","phase":"PHASE2, PHASE3","overall_status":"TERMINATED","enrollment_count":5,"lead_sponsor_name":"Laboratoires Thea","has_results":true},{"nct_id":"NCT03831594","title":"Combining Physical Therapy With Vestibular Stimulation to Improve Postural Stability in Pusher's Syndrome","phase":"NA","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Imperial College London","has_results":false}],"total":19},"guidelines":[],"source":"Drug Landscape verified database"}